R.PR
REGISTERED-PRINCIPAL REGISTER
14/09/2021
Voltar para busca
Dado oficial do USPTO
MMX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
14/09/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 44
Data de depósito
04/03/2020
Data de registro
14/09/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/09/2021
Última transação
14/09/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
11
Localização do titular
Rochester, NY, IE
Examinador
CANTOR, JILLIAN
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cosmo Technologies Ltd
Representantes
John Pickerill Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Contrast media for use with medical equipment or in medical imagingendoscopyx-rayultrasoundMRIPET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substancesprescription medicines in the form of pillstabletscapsulescapletsliquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disordersgastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicinespillstabletscapsulescapletsliquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agentspreparations and substances for medical purposesthe visual enhancing or visualization of polypsadenomascarcinomasearly stage cancers and other lesions in the colon for patients undergoing endoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopicendoscopiccolonoscopicsigmoidoscopicanoscopicrectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detectiondiagnosisprevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterologyendoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceuticalmedical and surgical purposesdetectiondiagnosisprevention or treatment of gastroenterological diseases; Medical and surgical dyesmethylene blue dye; Medical dyes for pharmaceutical and diagnostic purposesthe visual enhancing or visualization of polypsadenomascarcinomasearly stage cancers and other lesions in the colon for patients undergoing endoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; pharmaceutical preparations for the diagnosisprevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertilityreproductive healthhematologyurologygynecologyobstetricsendocrinologyoncologyrenalologyimmunology and inflammatory diseasesdisorders and conditions; pharmaceutical preparations for colon and digestive system health and regulationfor improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrheadiarrheadiverticular diseasediverticulitis or infectious colitis
Classe 44
Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/06/2021
PUBO
PUBLISHED FOR OPPOSITION
29/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
19/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
19/03/2021
CNSL
SUSPENSION LETTER WRITTEN
19/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2021
ALIE
ASSIGNED TO LIE
10/03/2021
NREV
NOTICE OF REVIVAL - E-MAILED
08/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2020
PETG
PETITION TO REVIVE-GRANTED
07/12/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
07/12/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
04/12/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
04/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/11/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
19/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/11/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/05/2020
GNRT
NON-FINAL ACTION E-MAILED
20/05/2020
CNRT
NON-FINAL ACTION WRITTEN
20/05/2020
DOCK
ASSIGNED TO EXAMINER
20/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2020
NWAP
NEW APPLICATION ENTERED
07/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MMX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.